The purpose of this study was to identify the major salivary components which interact with oral bacteria and to determine the mechanism(s) responsible for their binding to the bacterial surface. Strains of Streptococcus sanguis, Streptococcus mitis, Streptococcus mutans, and Actinomyces viscosus were incubated for 2 h in freshly collected human submandibular-sublingual saliva (HSMSL) or parotid saliva (HPS), and bound salivary components were eluted with 2% sodium dodecyl sulfate. By sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western transfer, a-amylase (EC 3.2.1.1) was the prominent salivary component eluted from S. sanguis. Studies with _251-labeled HSMSL or 125I-labeled HPS also demonstrated a component with an electrophoretic mobility identical to that of a-amylase which bound to S. sanguis. Purified oa-amylase from human parotid saliva was radiolabeled and found to bind to strains of S. sanguis genotypes 1 and 3 and S. mitis genotype 2, but not to strains of other species of oral bacteria. Binding of [1251]ot-amylase to streptococci was saturable, calcium independent, and inhibitable by excess unlabeled oi-amylases from a variety of sources, but not by secretory immunoglobulin A and the proline-rich glycoprotein from HPS. Reduced and alkylated a-amylase lost enzymatic and bacterial binding activities. Binding was inhibited by incubation with maltotriose, maltooligosaccharides, limit dextrins, and starch. * Corresponding author. been shown to interact with various oral bacteria in vitro. These include mucins (20,28,37,38), proline-rich glycoprotein (5, 56), secretory immunoglobulin A (sIgA) (40, 64), a fucose-rich glycoprotein from parotid saliva (16), lysozyme (25, 52), P2-microglobulin (15), and others (3,4). The goal of the present study was to ascertain to what extent salivary components interact with S. sanguis and other bacteria and to determine the mechanism(s) responsible for their binding to the bacterial surface.
MATERIALS AND METHODSMaterials. The following materials were obtained from the indicated sources: Trypticase soy broth (TSB) and agar (BBL Microbiology Systems, Cockeysville, Md.); yeast extract (Difco Laboratories, Detroit, Mich.); crude human salivary a-amylase, Bacillus amyloliquefaciens ot-amylase, Aspergillus oryzae ox-amylase, porcine pancreatic a-amylase, Triticum aestivum (wheat seed) a-amylase inhibitor, D-glucose, D-galactose, lactose, D-mannose, maltose, maltotriose, maltooligosaccharide, pullulan (limit dextrin)